|
⚲
|
| Keyboard |
| Paladin Capital Group III LLC
✚
|
|
|---|---|
| CIK # | 0001788499 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788499] | |
| 4 | [0001788499] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-04-30 | Sell | 1,000,000 | $78.25 | 78,250,000 |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-04-21 | Sell | 568 | $74.48 | 42,305 |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-03-17 | Other | 1,527,241 | $0.00 | |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-03-16 | Other | 619,306 | $0.00 | |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-02-20 | Conversion | 8,675,167 | ||
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2020-02-20 | Conversion | 8,675,167 | ||
|
10x Genomics Inc TXG
Series A-1 Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 790,487 | $0.00 | |
|
10x Genomics Inc TXG
Series D Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 653,082 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 790,487 | $0.00 | |
|
10x Genomics Inc TXG
Series B Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 2,476,963 | $0.00 | |
|
10x Genomics Inc TXG
Series A-2 Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 3,749,767 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 1,004,868 | $0.00 | |
|
10x Genomics Inc TXG
Series C Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 1,004,868 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 2,476,963 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 653,082 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 3,749,767 | $0.00 |